|
|
Volumn 14, Issue 31, 2008, Pages 3295-3296
|
|
Editorial: PET and SPECT in drug evaluation and drug design imaging inflammatory processes, tumors, and the endocannabinoid system
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMYLOID BETA PROTEIN ANTIBODY;
ANGIOGENESIS INHIBITOR;
ANTIDEPRESSANT AGENT;
APOPTOSIS INHIBITOR;
BENZODIAZEPINE RECEPTOR;
CANNABINOID 1 RECEPTOR;
CANNABINOID 1 RECEPTOR AGONIST;
CANNABINOID 1 RECEPTOR ANTAGONIST;
CHOLINESTERASE INHIBITOR;
COPPER 64;
ENDOCANNABINOID;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
FLUORODEOXYGLUCOSE F 18;
GALLIUM 68;
GROWTH FACTOR;
INDIUM 111;
IODINE 123;
IODINE 124;
IODINE 131;
LAPATINIB;
RADIOPHARMACEUTICAL AGENT;
TECHNETIUM 99M;
TRASTUZUMAB;
DIAGNOSTIC AGENT;
BRAIN DEGENERATION;
BREAST CANCER;
CLINICAL EFFECTIVENESS;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC VALUE;
DRUG DESIGN;
DRUG DISTRIBUTION;
DRUG RESEARCH;
DRUG RESPONSE;
DRUG SCREENING;
DRUG TARGETING;
EDITORIAL;
HUMAN;
INFLAMMATION;
ISOTOPE LABELING;
MOLECULAR BIOLOGY;
MOLECULAR IMAGING;
NON INVASIVE PROCEDURE;
NUCLEAR MEDICINE;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
PROTEIN TARGETING;
RECEPTOR DOWN REGULATION;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
TREATMENT PLANNING;
CHEMISTRY;
METABOLISM;
NEOPLASM;
SCINTISCANNING;
DRUG DESIGN;
ENDOCANNABINOIDS;
HUMANS;
INFLAMMATION;
NEOPLASMS;
POSITRON-EMISSION TOMOGRAPHY;
RADIOPHARMACEUTICALS;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
|
|
EID: 59649124867
PISSN: 13816128
EISSN: None
Source Type: Journal
DOI: 10.2174/138161208786549407 Document Type: Editorial |
|
Times cited : (1)
|
|
References (6)
|
